Literature DB >> 19815506

Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells.

Jihoon Chang1, Steven L Kunkel, Cheong-Hee Chang.   

Abstract

IL-10 produced by dendritic cells (DC) can limit or terminate ongoing inflammatory responses by inhibiting the proinflammatory cytokine production. Currently, the molecular mechanism by which IL-10 suppresses cytokine production is still ill-defined. In this study, we showed that IL-10 produced by DC dampens myeloid differentiation factor (MyD)88-dependent, but not MyD88-independent signaling. At the molecular level, IL-10 induces ubiquitination and subsequent protein degradation of MyD88-dependent signaling molecules, including IL-1 receptor-associated kinase 4 and TNF-receptor associated factor 6. Protein degradation by IL-10 was associated with decreased phosphorylation of p38, JNK, and IKK. All of these events were prevented by either blocking IL-10 receptor signaling or inhibiting proteasome degradation. IL-10 induced LPS hyporesponsiveness using the same mechanisms, i.e., ubiquitination and protein degradation. Thus, a previously undescribed regulatory mechanism by which IL-10-mediated protein degradation contributes to the inhibition of inflammatory cytokine production and endotoxin tolerance in DC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815506      PMCID: PMC2775313          DOI: 10.1073/pnas.0905815106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Negative regulation of toll-like receptor-mediated immune responses.

Authors:  Foo Y Liew; Damo Xu; Elizabeth K Brint; Luke A J O'Neill
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

Review 2.  Dectin-1: a signalling non-TLR pattern-recognition receptor.

Authors:  Gordon D Brown
Journal:  Nat Rev Immunol       Date:  2006-01       Impact factor: 53.106

3.  Interleukin-10 inhibits interferon-gamma-induced intercellular adhesion molecule-1 gene transcription in human monocytes.

Authors:  S Song; H Ling-Hu; K A Roebuck; M F Rabbi; R P Donnelly; A Finnegan
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

Review 4.  New insights into the molecular mechanism of interleukin-10-mediated immunosuppression.

Authors:  Gerald Grütz
Journal:  J Leukoc Biol       Date:  2004-11-02       Impact factor: 4.962

5.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

Authors:  K Takeda; B E Clausen; T Kaisho; T Tsujimura; N Terada; I Förster; S Akira
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

6.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.

Authors:  A B Lentsch; T P Shanley; V Sarma; P A Ward
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

8.  Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells.

Authors:  Michael Lotz; Dominique Gütle; Sabrina Walther; Sandrine Ménard; Christian Bogdan; Mathias W Hornef
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

9.  Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells.

Authors:  Yongxue Yao; Wei Li; Mark H Kaplan; Cheong-Hee Chang
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

10.  Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta.

Authors:  F Randow; U Syrbe; C Meisel; D Krausch; H Zuckermann; C Platzer; H D Volk
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  54 in total

1.  MTA1 coregulator regulates LPS response via MyD88-dependent signaling.

Authors:  Suresh B Pakala; Sirigiri Divijendra Natha Reddy; Tri M Bui-Nguyen; Siddharth S Rangparia; Anitha Bommana; Rakesh Kumar
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

2.  Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus.

Authors:  Haoyang Zhuang; Shuhong Han; Pui Y Lee; Ravil Khaybullin; Stepan Shumyak; Li Lu; Amina Chatha; Anan Afaneh; Yuan Zhang; Chao Xie; Dina Nacionales; Lyle Moldawer; Xin Qi; Li-Jun Yang; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2017-05-05       Impact factor: 10.995

3.  Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination.

Authors:  Diana Llopiz; Fernando Aranda; Nancy Díaz-Valdés; Marta Ruiz; Stefany Infante; Virginia Belsúe; Juan José Lasarte; Pablo Sarobe
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

4.  TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.

Authors:  Dusan Bogunovic; Olivier Manches; Emmanuelle Godefroy; Alice Yewdall; Anne Gallois; Andres M Salazar; Isabelle Marie; David E Levy; Nina Bhardwaj
Journal:  Cancer Res       Date:  2011-07-05       Impact factor: 12.701

5.  IRAK-M modulates expression of IL-10 and cell surface markers CD80 and MHC II after bacterial re-stimulation of tolerized dendritic cells.

Authors:  Tyler S Cole; Min Zhang; Theodore J Standiford; Michael Newstead; Jay Luther; Jiajie Zhang; Chun-Chia Chen; John Y Kao
Journal:  Immunol Lett       Date:  2012-03-28       Impact factor: 3.685

Review 6.  Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.

Authors:  Dror S Shouval; Jodie Ouahed; Amlan Biswas; Jeremy A Goettel; Bruce H Horwitz; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 7.  Trichinella spiralis: shaping the immune response.

Authors:  Natasa Ilic; Alisa Gruden-Movsesijan; Ljiljana Sofronic-Milosavljevic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 8.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

Authors:  Ankit Saxena; Sam Khosraviani; Sanjeev Noel; Divya Mohan; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cytokine       Date:  2014-12-04       Impact factor: 3.861

Review 9.  Toll-like receptors in inflammatory bowel diseases: a decade later.

Authors:  Elke Cario
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

10.  MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling.

Authors:  Jihoon Chang; Patrick R Burkett; Christopher M Borges; Vijay K Kuchroo; Laurence A Turka; Cheong-Hee Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.